Simple Patent License Agreement

To view standard confidentiality agreements, material transfer agreements or research cooperation agreements, please return to our Model Agreements page. With regard to exclusive licensees, another question to be considered by the licensor is whether it wishes to be able to exercise the intellectual property rights for which it envisages the grant of an exclusive licence, since the reservation of the right to exercise the intellectual property rights at issue vis-à-vis the licensor does not render the licence exclusive. Speaking to a lawyer about this decision can help you determine the appropriate modus operandi for your business. It is often necessary to include provisions in license agreements after termination. These may include the measures that each party must take when the agreement ends; obligations and acts that stop and continue at the end of the contract and whether or not there is a difference depending on whether the contract ends by expiry or by proactive termination by a party; A discussion of confidential information and the work of the parties; final reporting requirements for all elements contained in development; or final accounting requirements and payments between the parties. A lawyer can help you decide what are the appropriate provisions for your license agreement after termination. A patent license agreement is a contract between the patent owner, the licensor, and another, the licensee that gives the licensee the right to use, develop, manufacture or sell the patented technology or process, rights otherwise reserved exclusively to the patent owner. A patent gives its owner exclusive rights to manufacture, use, offer and sell the patented technology or process. See 35 U.S.C§154. The licensor may grant either of these rights. A license is not a sale and the licensor remains the owner of the patent.

Thus, patent licenses allow an inventor to commercialize his invention, commercialize it, produce it at a level higher than his individual capabilities and thus maximize the potential for remuneration of a new technology or process. A reference to global access — the development of technologies from Harvard patents can lead to licensed products that could have significant public health benefits in developing countries. By participating in universities Allied for Essential Medicines, Harvard is committed to promoting affordable access to these products in developing countries. . . .

This entry posted in Uncategorized. Bookmark the permalink. 

Comments are closed.